A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA
Clinical trial NCT06535685 · UNKNOWN
Trial details
- NCT number
- NCT06535685
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-02
- Primary completion
- 2025-03-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.